Search Result "phosphoinositide 3-kinase (PI-3k)"
Post-Wortmannin Era: Novel Phosphoinositide 3-Kinase Inhibitors with Potential Therapeutic Applications
Journal: Current Enzyme Inhibition
Volume: 5 Issue: 2 Year: 2009 Page: 66-86
Author(s): Laura Braccini, Fulvio Morello, Alessia Perino, Emilio Hirsch
The Phosphoinositide 3-Kinase Pathway in Human Cancer: Genetic Alterations and Therapeutic Implications
Journal: Current Genomics
Volume: 8 Issue: 5 Year: 2007 Page: 271-306
Author(s): Alexandre Arcaro, Ana S. Guerreiro
New 1H-pyrazolo[3,4-d]pyrimidin-1-yl)ethyl)-2-phenylisoquinoline-1(2H)-onesas Phosphoinositide 3-kinase Inhibitors for Treating Cancer and Other Diseases
Journal: Recent Patents on Anti-Cancer Drug Discovery
Volume: 19 Issue: 2 Year: 2024 Page: 253-255
Author(s): Surya K. De
Wnt1 Inducible Signaling Pathway Protein 1 (WISP1) Blocks Neurodegeneration through Phosphoinositide 3 Kinase/Akt1 and Apoptotic Mitochondrial Signaling Involving Bad, Bax, Bim, and Bcl-xL
Journal: Current Neurovascular Research
Volume: 9 Issue: 1 Year: 2012 Page: 20-31
Author(s): Shaohui Wang, Zhao Zhong Chong, Yan Chen Shang, Kenneth Maiese
Resveratrol Inhibits the Epithelial-Mesenchymal Transition of Pancreatic Cancer Cells Via Suppression of the PI-3K/Akt/NF-κB Pathway
Journal: Current Medicinal Chemistry
Volume: 20 Issue: 3 Year: 2013 Page: 4185-4194
Author(s): Wei Li, Jiguang Ma, Qingyong Ma, Bin Li, Liang Han, Jiangbo Liu, Qinhong Xu, Wanxing Duan, Shuo Yu, Fengfei Wang, Erxi Wu
Avoidance of Aβ[25-35] / (H2O2) -Induced Apoptosis in Lymphocytes by the Cannabinoid Agonists CP55, 940 and JWH-015 via Receptor-Independent and PI3K-Dependent Mechanisms: Role of NF- κB and p53
Journal: Medicinal Chemistry
Volume: 2 Issue: 5 Year: 2006 Page: 471-479
Author(s): C. Velez-Pardo, M. Jimenez Del Rio
Adhesion Molecules and Kinases Involved in γ δ T Cells Migratory Pathways:Implications for Viral and Autoimmune Diseases
Journal: Current Medicinal Chemistry
Volume: 14 Issue: 3 Year: 2007 Page: 3166-3170
Author(s): Alessandro Poggi, Silvia Catellani, Daniela Fenoglio, Giovanna Borsellino, Luca Battistini, Maria Raffaella Zocchi
PIP3 Regulation as Promising Targeted Therapy of Mast-Cell-Mediated Diseases
Journal: Current Pharmaceutical Design
Volume: 17 Issue: 3 Year: 2011 Page: 3815-3822
Author(s): Bruce J. Shenker, Hydar Ali, Kathleen Boesze-Battaglia
PI3K/Akt/JNK/c-Jun Signaling Pathway is a Mediator for Arsenite- Induced Cyclin D1 Expression and Cell Growth in Human Bronchial Epithelial Cells
Journal: Current Cancer Drug Targets
Volume: 9 Issue: 4 Year: 2009 Page: 500-509
Author(s): Jin Ding, Beifang Ning, Yi Huang, Dongyun Zhang, Jingxia Li, Chang-Yan Chen, Chuanshu Huang
The Akt Pathway: Molecular Targets for Anti-Cancer Drug Development
Journal: Current Cancer Drug Targets
Volume: 4 Issue: 3 Year: 2004 Page: 235-256
Author(s): Constantine S. Mitsiades, Nicholas Mitsiades, Michael Koutsilieris